Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice

Kidney International

Volumn 51, Issue 1, 1997, Pages 94-103

  Huang, Xiao Ru ^a   Tipping, Peter G ^a,b   Shuo, L I ^a   Holdsworth, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GLOBULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

EID: 0031058573     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.12     Document Type: Article

References (36)

1. TIPPING PG, NEALE TJ, HOLDSWORTH SR: T lymphocyte participation in antibody induced experimental glomerulonephritis. Kidney Int 27:530-537, 1985
2. BOYCE NW, TIPPING PG, HOLDSWORTH SR: Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int 30:673-677, 1986
3. OITE T, SHIMIZU F, KAGAMI S, MORIOKA T: Hapten-specific cellular immune response producing glomerular injury. Clin Exp Immunol 76:463-468, 1989
4. BHAN AK, SCHNEEBERGER EE, COLLINS AD, MCCLUSKEY RT: Evidence for a pathogenic role for a cell mediated immune mechanism in experimental glomerulonephritis. J Exp Med 148:246-260, 1978
5. BHAN AK, COLLINS AB, SCHNEEBERGER EE, MCCLUSKEY RT: A cell mediated reaction against glomerular hound immune complexes. J Exp Med 148:246-260, 1979
6. BOLTON WK, CHANDRA M, TYSON TM, KIRKPATRICK PR, SADOVNIC MJ, STURGILL BC: Transfer of experimental glomerulonephritis in chickens by mononuclear cells. Kidney Int 34:598-610, 1988
7. HUANG XR, HOLDSWORTH SR, TIPPING PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46:69-78, 1994
8. KAWASAKI K, YAOITA E, YAMAMOTO T, KIHARA I: Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 41:1517-1526, 1992
9. BOLTON WK, INNES DJ JR, STURGILL BC, KAISER DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations. Kidney Int 32:869-876, 1987
10. NOLASCO FE, CAMERON JS, HARTLEY B, COELHO A, HILDRETH G, REUBEN R: Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31:1160-1166, 1987
11. NEALE TJ, TIPPING PG, CARSON SD, HOLDSWORTH SR: Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 2:421-424, 1988
12. STACHURA I, SI L, WHITESIDE TL: Mononuclear cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): Analysis in tissue sections with monoclonal antibodies. J Clin Immunol 4:202-208, 1984
13. STILMAN MM, BOLTON WK, STURGILL BC, SCHMITT GW, COUSER WG: Crescentic glomerulonephritis without immune deposits. Clinicopathological features. Kidney Int 15:184-195, 1979
14. MOSMANN TR, COFFMAN RL: Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111-147, 1989
15. CHER DJ, MOSMANN TR: Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138:3688-3694, 1987
16. FONG TA, MOSMANN TR: The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J Immunol 143:2887-2893, 1989
17. MOCCI S, COFFMAN RL: Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J Immunol 154:3779-3787, 1995
18. LI L, ELLIOTT JF, MOSMANN TR: IL-10 inhibits cytokine production, vascular leakage and swelling during T helper cell-induced delayed-type hypersensitivity. J Immunol 153:3967-3977, 1994
19. GAJEWSKI TF, FITCH FW: Anti-proliferative effect of IFNγ in immune regulation. I. IFNγ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245-4252, 1988
20. SADICK MD, HEINZEL FP, SHIGEKANE VM, FISHER WL, LOCKSLEY RM: Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. J Immunol 139:1303-1309, 1987
21. HEINZEL FP, SADICK MD, HOLADAY BJ, COFFMAN RL, LOCKSLEY RM: Reciprocal expression of interferon y or interleukin 4 during resolution or progression of murine Leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59-72, 1989
22. LIBLAU RS, SINGER SM, MCDEVITT HO: Th1 and Th2 CD4-T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38, 1995
23. TIPPING PG, HUANG XR, BERNDT MC, HOLDSWORTH SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 46:79-88, 1994
24. TIPPING PG, HUANG XR, BERNDT MC, HOLDSWORTH SR: P-selectin directs T lymphocyte mediated injury in delayed type hypersensitivity responses: Studies in glomerulonephritis and cutaneous delayed type hypersensitivity. Eur J Immunol 26:454-460, 1996
25. BRADFORD MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
26. SPITALNY GL, HAVELL EA: Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med 159:1560-1565, 1984
27. WOFSY D, SEAMAN WE: Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161:378-391, 1985
28. RANGES GE, SRIRAM S, COOPER SM: Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 162:1105-1110, 1985
29. BELOSEVIC M, FINBLOOM DS, VAN DER MEIDE PH, SLAYTER MV, NACY CA: Administration of anti-IFNγ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 143:266-274, 1989
30. DUONG TT, FINKELMAN FD, SINGH S, STREJAN GH: Effect of anti interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mice strains. J Neuroimmunol 53:101-107, 1994
31. BOISSIER M-C, CHIOCCHIA G, BESSIS N, HAJNAL J, GAROTTA G, NICOLETTI F, FOURNIER C: Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol 25:1184-1190, 1995
32. KOYAMA A, INAGE H, KOBAYASHI M, NARITA M, TOJO S: Effect of chemical cationization of antigen on glomerular localization of immune complexes in active models of serum sickness nephritis in rabbits. Immunology 58:535-540, 1986
33. GOLBUS SM, WILSON CB: Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall. J Clin Invest 16:148-157, 1979
34. CAMPBELL IL, KAY TWH, OXBROW L, HARRISON L: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1991
35. DEBRAY-SACHS M, CARNAUD C, BOITARD C, COHEN H, GRESSER I, BEDOSSA P, BACH JF: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 4:237-248, 1991
36. OZMEN L, ROMAN D, FOUNTOULAKIS M, SCHMID G, RYFFEL B, GAROTTA G: Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6-12, 1995